Policies & Research

New Improved Hepatitis B Medicine to be Considered for Pharmaceutical Benefits Scheme

As Australians with hepatitis C are being cured at unprecedented rates, there is promise of a better medicine for those living with chronic hepatitis B who need treatment. The Pharmaceutical Benefits Advisory …

AIVL Applauds Greens’ New Drug Policy

The national organisation representing people who use drugs, AIVL has applauded the Australian Greens’ courageous leadership in adopting an evidence-based drug policy that focuses on saving lives. The Australian Greens …

Saliva, Cricket and Viral Diseases – Hysteria Resurfaces

Misinformation has reared its ugly head again as South Australians waded into the debate over the Du Plessis ball tampering drama. The South African cricket captain’s controversial habit of polishing …

Quite Little, Very Late – Government response to Silent Disease Report

The Federal Government’s response to the ‘Silent Disease’ inquiry into hepatitis C in Australia falls well short of what anyone living with hepatitis C could have hoped. Coming nearly 18 months …
Knitted dolls in a shop

Treating Children with HBV – Predictors of Success

A unique longitudinal real life study on entecavir-treated children and adolescents have found that HBV DNA results at six and twelve months after starting treatment, are predictors of viral suppression. Another predictor …

Clinical Trials Find Home at New RAH

Minister for Health, Jack Snelling, has confirmed today that most researchers undertaking existing clinical trials as well as new trials being planned, will be housed within the new Royal Adelaide …

New RAH Will Accommodate Clinical Trials – Health Minister

Research and clinical trials directly involving patients will have access to clinical settings and flexible workspaces at the new Royal Adelaide Hospital (RAH), according to Minister for Health, Jack Snelling. …
blood test in a lab

Will South Australians Miss Out on Future Cures?

It is a rare thing that a cure can be found for a chronic disease. Yet such a thing did happen recently with the revolution in treatments for hepatitis C. …